Aye C, Williams M, Horvath R
Infection Management Unit, The Prince Charles Hospital, Brisbane, QLD 4032, Australia; School of Medicine, University of Queensland, Brisbane, QLD, Australia.
Department of Pharmacy, The Prince Charles Hospital, Brisbane, QLD 4032, Australia.
Case Rep Infect Dis. 2017;2017:1402320. doi: 10.1155/2017/1402320. Epub 2017 Mar 13.
Mycotic pseudoaneurysm of aorta following cardiac surgery is rare but is highly fatal if it is unrecognized and untreated. Here, we report a case of a 45-year-old male patient who presented with rapidly progressive multiple pseudoaneurysms of the ascending aorta infected with multidrug resistant (MDR) 5 weeks after cardiac transplantation, on a background of prior bridging therapy with left ventricular assistant device (LVAD). The patient was successfully treated with the newer cephalosporin, Ceftolozane/Tazobactam, in combination with surgery. This is the first reported case of mycotic pseudoaneurysm infected with MDR . This case also highlights the importance of high vigilance and timely multimodality treatment in the diagnosis and management of mycotic pseudoaneurysm following cardiac transplant, especially in patients who had LVAD.
心脏手术后发生的主动脉霉菌性假性动脉瘤较为罕见,但如果未被识别和治疗则具有很高的致死率。在此,我们报告一例45岁男性患者,该患者在心脏移植术后5周出现升主动脉多发快速进展性假性动脉瘤,感染了多重耐药菌(MDR),其前期接受过左心室辅助装置(LVAD)的桥接治疗。该患者通过使用新型头孢菌素头孢洛扎/他唑巴坦联合手术成功治愈。这是首例报道的感染多重耐药菌的霉菌性假性动脉瘤病例。该病例还凸显了在心脏移植术后霉菌性假性动脉瘤的诊断和管理中保持高度警惕并及时采取多模式治疗的重要性,尤其是对于接受过LVAD治疗的患者。